Pathkey.AI completes Chipforge acquisition to expand AI chip design capabilities

Acquisition Finalised with Significant Equity Consideration

Pathkey.AI Ltd (ASX:PKY) has closed the acquisition of Singapore-based Chipforge Pte Ltd, a company developing an AI-powered semiconductor hardware design platform. The deal was settled through the issuance of 560 million fully paid ordinary shares and 150 million performance rights, subject to milestone vesting conditions.

Chipforge’s technology promises to disrupt the traditionally lengthy and costly semiconductor design process, which can take 12 to 24 months and millions of dollars. By leveraging an Agentic AI platform that converts high-level design intent into verified, synthesisable hardware code, Chipforge aims to drastically shorten development cycles.

Chipforge’s Agentic AI Platform Targets Semiconductor Bottlenecks

At the core of Chipforge’s offering is a proprietary Agent-Based AI architecture combined with large-language-model functionality and a closed-loop reflection methodology. This workflow automates design, verification, and synthesis on FPGA hardware, with plans to extend towards full ASIC development.

The platform is positioned to serve sectors where custom semiconductor design is critical, including defence, aerospace, critical infrastructure, and AI edge computing. This aligns with growing global demand for sovereign chip design and local control over critical technology.

Strategic Synergies Between Chipforge and TrialKey Platforms

Pathkey’s existing TrialKey platform, focused on clinical trial design optimisation, shares the same agent-based AI architecture as Chipforge. The company anticipates material cross-platform synergies, with engineering advances and data-pipeline methodologies developed for one platform applicable to the other.

Pathkey’s CEO Andrew Farnsworth highlighted the strategic significance, noting the acquisition extends the company’s AI capabilities beyond healthcare into semiconductor engineering, a sector known for its complexity and talent constraints. Farnsworth also emphasised the value of the exclusive worldwide licence to intellectual property developed at Nanyang Technological University, underpinning Chipforge’s technology.

Licence Agreement and Governance Implications

Chipforge holds an exclusive, worldwide licence from Ntuitive Pte Ltd, affiliated with Nanyang Technological University, which includes rights to sublicense. The licence is subject to development, commercialisation, and revenue commitments, alongside annual fees.

Under the acquisition terms, Chipforge may nominate a non-executive director to Pathkey’s board within 12 months, a right not yet exercised. This could influence governance as integration progresses.

Next Steps and Market Positioning

Pathkey intends to continue developing both TrialKey and Chipforge platforms, aiming to demonstrate Chipforge’s commercial viability swiftly. The acquisition represents a significant step in Pathkey’s ambition to build a scalable, defensible AI ecosystem spanning multiple high-value industries.

The move also positions Pathkey to meet rising global demand for sovereign and locally controlled semiconductor design capabilities, a strategic priority amid geopolitical pressures on technology supply chains.